The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Moskvina L.V.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossii

Andreeva Yu.Yu.

Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia

Frank G.A.

Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena Rosmedtekhnologiĭ, Moskva

Zavalishina L.É.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdravsotsrazvitiia Rossii

Petrov A.N.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava RF

Mal'kov P.G.

GUNU "Fakul'tet fundamental'noĭ meditsiny MGU im. M.V. Lomonosova";
GBOU DPO "Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia", Moskva

Prognostic value of the expression of adhesion molecules for non-clear-cell variants of renal cell carcinoma

Authors:

Moskvina L.V., Andreeva Yu.Yu., Frank G.A., Zavalishina L.É., Petrov A.N., Mal'kov P.G.

More about the authors

Journal: Russian Journal of Archive of Pathology. 2013;75(4): 3‑8

Read: 1136 times

Download PDF (RU)
Contact the author
Table of contents

PROGNOSTIC VALUE OF THE EXPRESSION OF ADHESION MOLECULES FOR NON-CLEAR-CELL VARIANTS OF RENAL CELL CARCINOMA
PROGNOSTIC VALUE OF THE EXPRESSION OF ADHESION MOLECULES FOR NON-CLEAR-CELL VARIANTS OF RENAL CELL CARCINOMA

To cite this article:

Moskvina LV, Andreeva YuYu, Frank GA, Zavalishina LÉ, Petrov AN, Mal'kov PG. Prognostic value of the expression of adhesion molecules for non-clear-cell variants of renal cell carcinoma. Russian Journal of Archive of Pathology. 2013;75(4):3‑8. (In Russ.)

Подписка 2025-2 (Russian Journal of Archive of Pathology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Mediasphera_Net
Close metadata
Recommended articles:
The role of immu­nohistochemical examination in the differential diagnosis of atypical tumors and carcinomas of para­thyroid glands. Russian Journal of Archive of Pathology. 2024;(4):5-12
Alveolar adenoma of the lung. Russian Journal of Archive of Pathology. 2024;(4):38-41
Cardiac myxoma: biological features, morphology, differential diagnosis. Russian Journal of Archive of Pathology. 2024;(6):74-81
Hypoalbuminemia as an inde­pendent predictor of complications, critical illness and premature death. Russian Journal of Anesthesiology and Reanimatology. 2024;(4):83-89
Prediction of papi­llary thyroid cancer recu­rrence acco­rding to preoperative data. Piro­gov Russian Journal of Surgery. 2024;(9):76-85
Prognostic value of right ventricular dysfunction in patients with left ventricular non-compaction cardiomyopathy. Russian Cardiology Bulletin. 2024;(3):62-70
Prognostic scale for early dete­ction of various postoperative complications after thoracic aortic surgery: post-hoc analysis of biomarkers. Piro­gov Russian Journal of Surgery. 2024;(10):38-48
PET/CT with 11C-methionine as a predictor of disease-free survival in patients with IDH1 wild type diffuse glioma. Burdenko's Journal of Neurosurgery. 2024;(5):6-13
The role of biomarkers of endo­thelial dysfunction in predicting the progression of mild cognitive impairment in patients with cardiovascular risk factors. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):88-95
Immu­nohistochemical features and pathogenesis of hype­rextensible eyelids. Plastic Surgery and Aesthetic Medi­cine. 2024;(4):25-33

The prognostic value of the expression of the adhesion molecules CD44, EMA, and E-cadherin was studied using surgical specimens of 105 renal cell carcinomas (54 papillary, 39 chromophobic, and 12 clear-cell ones). Stages 3-4 tumors showed hyperexpression of all the above proteins (the distribution was estimated by ξ2 and Fisher's exact tests). Furthermore, CD44 was found to be an independent unfavorable factor to predict renal cell carcinoma: with its hyperexpression, the 5-year estimated survival rate decreased by 52% (Kaplan-Meier method; p=0.018). The expression of EMA and E-cadherin was significantly associated with the stage and, to some extent, grade of tumor differentiation; however, it is necessary to study more observations to define the prognostic role of these proteins.

Keywords:

non-clear-cell renal cell carcinoma
immunohistochemistry
prognosis

Authors:

Moskvina L.V.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossii

Andreeva Yu.Yu.

Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia

Frank G.A.

Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena Rosmedtekhnologiĭ, Moskva

Zavalishina L.É.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdravsotsrazvitiia Rossii

Petrov A.N.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava RF

Mal'kov P.G.

GUNU "Fakul'tet fundamental'noĭ meditsiny MGU im. M.V. Lomonosova";
GBOU DPO "Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia", Moskva

List of references:

  1. Eble J.N., Sauter G., Epstein J.I., Sesterhenn I.A. Tumors of the system and male genital organs. Lyon, France: IARC Press; 2004.
  2. Iczkowski K.A. Cell adhesion molecule CD44: its functional roles in prostate cancer. Am. J. Transl. Res. 2010; 3 (1): 1-7.
  3. Danilova N.V., Andreeva Yu.Yu., Zavalishina L.E., Mal'kov P.G. Markery stromal'noi invazii pri fonovykh i predrakovykh izmeneniyakh zhelezistogo epiteliya i adenokartsinome sheiki matki. Arkhiv patologii. 2012; 74 (4): 28-34.
  4. Kan M., Aki M., Akiyama K., Naruo S., Kanayama H., Kagawa S. High-level expression of the CD44 variant sharing exon v10 in renal cancer. Jpn. J. Cancer Res. 1995; 86 (9): 847-53.
  5. Terpe H.J., Störkel S., Zimmer U., Anquez V., Fischer C., Pantel K., Günthert U. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation. Am. J. Pathol. 1996; 148 (2): 453-63.
  6. Paradis V., Ferlicot S., Ghannam E., Zeimoura L., Blanchet P., Eschwége P. et al. CD44 is an independent prognostic factor in conventional renal cell carcinomas. J. Urol. 1999; 161 (6): 1984-7.
  7. de Alava E., Panizo A., Sola I., Rodríguez-Rubio F.I., Pardo-Mindán F.J. CD44v6 expression is related to progression in renal epithelial tumours. Histopathology. 1998; 33 (1): 39-45.
  8. Kroeze S.G., Bijenhof A.M., Bosch J.L., Jans J.J. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma. Cancer Biomark. 2010; 7 (6): 261-8.
  9. Yildiz E., Gokce G., Kilicarslan H., Ayan S., Goze O.F., Gultekin E.Y. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma. Br. J. Urol. Int. 2004; 93 (7): 1087-93.
  10. Ljungberg B., Cowan N., Hanbury D.C., Hora M., Kuczyk M.A., Merseburger A.S. et al. Pochechno-kletochnyi rak. 2011. http://www.uroweb.org/gls/pdf/russian/4_Renall_Cell_Carcinoma.pdf
  11. Li Y., Kuwahara H., Ren J. et al. The c-Src tyrosinase kinase regulates signalling of the human DF3/MUC1 carcinoma-associated antigen with GSK3 beta and beta-catenin. J. Biol. Chem. 2001; 276: 6061-4.
  12. Langner C., Ratschek M., Rehak P., Schips L., Zigeuner R. Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases. Mod. Pathol. 2004; 17 (2): 180-8.
  13. Bamias A., Chorti M., Deliveliotis C. et al. Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma. Urology. 2003; 62: 368-73.
  14. Denda-Nagai K., Fujita K., Fujime M. et al. Absence of correlation of MUC1 expression to malignant behavior of renal cell carcinoma in experimental systems. Clin. Exp. Metast. 2000; 18: 77-81.
  15. Aubert S., Fauquette V., Hémon B., Lepoivre R., Briez N., Bernard D. et al. MUC1, a new hypoxia inducible factor target gene, is an actor in clear renal cell carcinoma tumor progression. Cancer Res. 2009; 69 (14): 5707-15. doi: 10.1158/0008-5472.CAN-08-4905.
  16. Shen S.S., Truong L.D., Scarpelli M., Lopez-Beltran A. Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful? Arch. Pathol. Lab. Med. 2012; 136 (4): 410-7.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.